Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 319-333
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.319
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.319
Experimental group (n = 27) | Control group (n = 28) | P value | |
Mean age (range, yr) | 52 (44-60) | 51 (40-62) | 0.516 |
Gender | |||
Male | 19 (70.4) | 21 (75) | 0.70 |
Female | 8 (29.6) | 7 (25) | |
Years of education | |||
< 9 | 8 (29.6) | 9 (32.2) | 0.747 |
9-12 | 15 (55.6) | 13 (46.4) | |
> 12 | 4 (14.8) | 6 (21.4) | |
Marital status | |||
Married | 20 (74.1) | 24 (85.7) | 0.555 |
Unmarried | 2 (7.4) | 1 (3.6) | |
Divorced | 5 (18.5) | 3 (10.7) | |
Clinical stage | |||
I | 3 (11.1) | 2 (7.2) | 0.763 |
II | 11 (40.8) | 10 (35.7) | |
III | 13 (48.1) | 16 (57.1) | |
Chemotherapy | |||
XELOX | 12 (44.4) | 10 (35.7) | 0.509 |
FOLOX | 15 (55.6) | 18 (64.3) | |
Mean BMI (kg/m2) | 22.56 (20.38-24.05) | 22.71 (21.22-24.19) | 0.561 |
Mean MMSE score | 24 (22-27) | 24 (22-27) | 0.765 |
- Citation: Lin ZG, Li RD, Ai FL, Li S, Zhang XA. Effects of cognitive behavior therapy combined with Baduanjin in patients with colorectal cancer . World J Gastrointest Oncol 2022; 14(1): 319-333
- URL: https://www.wjgnet.com/1948-5204/full/v14/i1/319.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.319